AI-derived body composition analysis reveals muscle volume and metformin-associated adipose effects and the obesity paradox in non-small cell lung cancer
Wang X., Hata A., Wada N., Song J., Fukuda T., Nakamura Y.
Retrospective Study with a reported sample of 93 on Hip, Systemic / IV, published in EBioMedicine (2025) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Retrospective Study
- Journal
- EBioMedicine (2025)
- Reported sample size
- 93
- Source database
- Europe PMC
- PMID
- 41166991
- PMCID
- PMC12613069
- DOI
- 10.1016/j.ebiom.2025.105995
- Citations
- 2
Abstract (original English)
Background Body composition is emerging as a prognostic factor in cancer, with metformin showing potential antitumour effects in patients with obesity and non-small cell lung cancer (NSCLC). We aimed to determine which specific body composition components drive survival differences in different patient subgroups and explore underlying molecular mechanisms. Methods In this retrospective cohort study, we analysed 1275 patients with confirmed NSCLC diagnosis and available chest CT imaging for body composition analysis at the Massachusetts General Hospital. Six body composition parameters (muscle density and volume, visceral adipose tissue [VAT], subcutaneous adipose tissue [SAT], VAT/SAT ratio, and intramuscular adipose tissue [IMAT]) were quantified using validated CNN-based segmentation algorithms from baseline CT scans. The primary outcome was overall survival (OS), assessed from diagnosis until death or last follow-up. Associations with OS were analysed using multivariable Cox proportional hazards model, followed by subgroup analyses by sex, BMI, diabetes, and metformin use. Circulating cytokine levels (n = 93) and oncogenic driver mutations (n = 646) from the imaging cohort and comprehensive tumour mutation profiles from an independent Memorial Sloan Kettering Cancer Center cohort (n = 5363) were analysed for mechanistic insights. Findings Muscle volume demonstrated a dose-re
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • Without an adequate control group, treatment effects cannot be separated from other factors.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Adipose-Derived Stem Cells in Traumatic Brain Injury: A Systematic Review of Preclinical Studies.
Systematic Review on Neuroinflammation, published in Tissue Eng Regen Med (2026) — summary generated from the PubMed abstract.
- 2026
Tissue Eng Regen Med - Level AMeta-analysisPubMed
Comparative efficacy of different doses of mesenchymal stem cells derived from different tissue sources for knee osteoarthritis: a systematic review and network meta-analysis of randomized controlled trials.
Meta-analysis with a reported sample of 602 on Knee Osteoarthritis, Osteoarthritis, Chronic Inflammation, Immune Modulation, published in PeerJ (2026) — summary generated from the PubMed abstract.
- 2026
- n = 602
PeerJ - Level AMeta-analysisPubMed
Efficacy of Stem Cell-Derived Exosomes in Promoting Diabetic Foot Ulcer Healing: A Meta-Analysis of Preclinical Animal Studies.
Meta-analysis on Diabetic Foot, Chronic Wound, published in J Diabetes Res (2026) — summary generated from the PubMed abstract.
- 2026
J Diabetes Res - Level ASystematic ReviewEurope PMC
The Role of Exosome-miRNA as Biomarkers of Alzheimer's Disease: A Systematic Review of Case-Control and Longitudinal Studies
Systematic Review with a reported sample of 3046 on Neuroinflammation, published in Actas Esp Psiquiatr (2026) — summary generated from the PubMed abstract.
- 2026
- n = 3046
Actas Esp Psiquiatr - Level AMeta-analysisEurope PMC
Exosome-based therapy for epilepsy: a systematic review and meta-analysis of preclinical studies
Meta-analysis on Neuroinflammation, published in Front Neurosci (2026) — summary generated from the PubMed abstract.
- 2026
Front Neurosci - Level AMeta-analysisEurope PMC
Efficacy of stem cell therapy for achilles tendon rupture: a systematic review and meta-analysis based on animal studies
Meta-analysis on Tendon Injury, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.
- 2026
Front Bioeng Biotechnol